We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
(Approval lapsed) Oxybutynin hydrochloride 5mg tablets (Morningside)
Section 19A approved medicine
(Approval lapsed) Oxybutynin hydrochloride 5mg tablets (Morningside)
Section 19A approval holder
Reach Pharmaceuticals Pty Ltd ABN 25 623 897 183
Phone
0478 061 879
Approved until
Status
Expired
Medicines in short supply/unavailable
DITROPAN oxybutynin hydrochloride 5mg tablet bottle AUST R: 48965
Indication(s)
Treatment of detrusor over-activity where conservative measures have failed.
Images
